http://www.endless5dollarpayments.com

Switching to Tirzepatide Outweighs Upping Dulaglutide Dose

NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and weight lowering than does escalating dulaglutide treatment. “Often, when we are with a patient who is not meeting treatment goals...

Get In Touch

345 West 86th Street Apt 102

9174367615

SRIKER78@GMAIL.COM

Follow Us
Flickr Photos

Copyright © 2024omega1medianewsglobalnetwork. All Rights Reserved http://www.endless5dollarpayments.com